Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of protease inhibitors and other biologically active compounds. Its structure supports peptide mimetic design, making it valuable in medicinal chemistry for creating enzyme inhibitors. The compound's ester and sulfonate groups facilitate specific reactivity and solubility properties useful in multi-step organic syntheses. Commonly employed in research settings for modifying peptide backbones and improving metabolic stability in drug candidates.